Home / Japan / SymBio Pharmaceuticals Limited
SymBio Pharmaceuticals Limited
Short position disclosed on November 2, 2026. JPX register read on November 4, 2026.
Evolution of the disclosed total
Open positions
| Fund | Twelve months | % of capital | Over the year | Since |
|---|---|---|---|---|
| Nomura International plc | 2.12% | new | November 2, 2026 | |
| モルガン・スタンレーmufg証券株式会社 | 0.53% | new | November 2, 2026 |
Get the moves on SymBio Pharmaceuticals Limited by mail, at most once a day.
There is no account to create. You give an address, you confirm it through a link, and every message contains a link to stop.
History of disclosures
Download 68 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats
Other companies sold short in Japan
- FLIGHT SOLUTIONS Inc. 12.10% of the capital sold short
- Datasection Inc. 11.70% of the capital sold short
- QD Laser,Inc. 11.57% of the capital sold short
- GNI Group Ltd. 10.86% of the capital sold short
- Oncolys BioPharma Inc. 10.84% of the capital sold short
- Metaplanet Inc. 10.27% of the capital sold short
- AIMECHATEC,Ltd. 9.68% of the capital sold short
- ReYuu Japan Inc. 9.50% of the capital sold short
- Kasumigaseki Capital Co.,Ltd. 9.49% of the capital sold short
- KLab Inc. 8.85% of the capital sold short
- Astroscale Holdings Inc. 8.80% of the capital sold short
- Hutzper Inc. 8.70% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, SymBio Pharmaceuticals Limited, source JPX, data as at November 2, 2026, https://www.quivad.com/action/symbio-pharmaceuticals-limited
Embed the chart
<iframe src="https://www.quivad.com/embed/action/symbio-pharmaceuticals-limited" width="600" height="280" title="SymBio Pharmaceuticals Limited" loading="lazy" style="border:0"></iframe>
Badge
<a href="https://www.quivad.com/action/symbio-pharmaceuticals-limited"><img src="https://www.quivad.com/action/symbio-pharmaceuticals-limited/badge.svg" alt="QuiVad, SymBio Pharmaceuticals Limited"></a>